Does Primerica (PRI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Primerica's strong licensed sales force, ensuring sales growth and policy persistency, and decision to exit the senior health market poise it well for growth.
Does Primerica (PRI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Primerica's (PRI) strong licensed sales force, ensuring sales growth and policy persistency, and its decision to exit the senior health market poise it for growth.
Primerica reported solid earnings and increased their dividend by 20%, showing confidence in their business and strong financial performance. The company has been consistently buying back shares, reducing outstanding shares by over 50% since becoming publicly traded. Exiting the unprofitable senior health segment of the business leaves the company more focused and ready to grow even faster in the future.
The headline numbers for Primerica (PRI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Primerica (PRI) came out with quarterly earnings of $4.71 per share, beating the Zacks Consensus Estimate of $4.45 per share. This compares to earnings of $3.99 per share a year ago.
Beyond analysts' top -and-bottom-line estimates for Primerica (PRI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Primerica (PRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Middle-income households are feeling the squeeze after years of elevated inflation, and 66% reported they are falling behind due to the high cost of living in the U.S.
Primerica (PRI) is set to grow on a compelling portfolio, strong market presence and a solid capital position.
NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") (NYSE:PRI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.